Effect of Vitamin E Supplementation on Lung Function and Quality of Life in Children with Pulmonary Tuberculosis

Effect of Vitamin E Supplementation on Lung Function and Quality of Life in Children with Pulmonary Tuberculosis: A randomized parallel group open label pilot trial - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109085

Enrollment

Registered

2026-04-22

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: Vitamin E: 200mg OD, Oral for 2 months Control Intervention1: standard Anti-tubercular therapy: intensive phase, first 2 months

Eligibility

Inclusion criteria

Inclusion criteria: 1.Confirmed or probable pulmonary TB cases 2.TB as per NTEP and WHO disease guidelines 3.Age 6 18 years

Exclusion criteria

Exclusion criteria: 1. Drug-resistant TB or HIV co-infection 2. Underlying Chronic liver/kidney disease 3. Vitamin E use with in last 14 days

Design outcomes

Primary

Measure	Time frame
Change in lung function at baseline, 2 months, and 6 months using spirometry and forced oscillometry.Timepoint: 5years	—

Secondary

Measure	Time frame
Change in Quality-of-Life (QOL) score measured by PeDsQL Pediatric QOL Inventory at baseline, 2 months, and 6 months.Timepoint: 5 years	—

Countries

India

Contacts

Public ContactDr Subhajit Hazra

All India Institute of Medical Sciences, RAJKOT

a2sachin23@gmail.com8859150624

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026